Eyal Yosefof

21PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersOral medicine and pathologySolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Craniofacial biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 15, 2026
The Global Immune-Nutrition-Inflammation Index (GINI) as a Candidate Prognostic Marker in Patients with Cutaneous Squamous Cell Carcinoma Treated with Cemiplimab.

|Jan 28, 2026
Value of Routine Follow-Up After Pleomorphic Adenoma Surgery.

Yehonatan Adler, Eyal Yosefof, Ben Giladi

|Jan 14, 2026
The Prognostic Significance of Elective Level 4 Neck Dissection in Oral Tongue Cancer.

Eyal Yosefof, Nofar Edri, Amit Ritter

|Sep 16, 2025
The Administration of Cetuximab-Based Regimen as a Second Line After Pembrolizumab Among Incurable Head and Neck Squamous Cell Carcinoma Patients.

Noga Kurman, Ido Even-Tov, Ofir Zavdy

|Jun 26, 2025
Applications for Circulating Cell-Free DNA in Oral Squamous Cell Carcinoma: A Non-Invasive Approach for Detecting Structural Variants, Fusions, and Oncoviruses.

Mahua Bhattacharya, Dan Yaniv, Dylan P D'Souza

|Mar 04, 2025
Treatment with programmed-death-1 inhibitors for non-melanoma skin cancer among immunocompromised patients with subgroup analysis of solid organ transplant patients.

Eyal Yosefof, Nofar Edri, Idan Ben-Nachum

Pageof 4

Frequent Collaborators

8 joint publications

Aviram Mizrachi

4 joint publications

Dan Yaniv

3 joint publications

Sharon Tzelnick

3 joint publications

Dean Dudkiewicz